-
1
-
-
0030982113
-
Antiangiogenesis for cancer therapy
-
AL Harris Antiangiogenesis for cancer therapy Lancet 349 1997 13 15
-
(1997)
Lancet
, vol.349
, pp. 13-15
-
-
Harris, AL1
-
2
-
-
15144358851
-
Angiopoietin-2, a natural antagonist for tie2 that disrupts in-vivo angiogenesis
-
PC Maisonpierre C Suri PF Jones Angiopoietin-2, a natural antagonist for tie2 that disrupts in-vivo angiogenesis Science 277 1997 55 60
-
(1997)
Science
, vol.277
, pp. 55-60
-
-
Maisonpierre, PC1
Suri, C2
Jones, PF3
-
3
-
-
0031001536
-
The preclinical evaluation of angiogenesis inhibitors
-
MS O'Reilly The preclinical evaluation of angiogenesis inhibitors Invest New Drugs 15 1997 5 13
-
(1997)
Invest New Drugs
, vol.15
, pp. 5-13
-
-
O'Reilly, MS1
-
4
-
-
0027970092
-
Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
-
MS O'Reilly L Holmgren Y Shing Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma Cell 79 1994 315 328
-
(1994)
Cell
, vol.79
, pp. 315-328
-
-
O'Reilly, MS1
Holmgren, L2
Shing, Y3
-
5
-
-
0031454617
-
Endostatin: an endogenous inhibitor of angiogenesis and tumour growth
-
MS O'Reilly T Boehm Y Shin Endostatin: an endogenous inhibitor of angiogenesis and tumour growth Cell 88 1997 277 285
-
(1997)
Cell
, vol.88
, pp. 277-285
-
-
O'Reilly, MS1
Boehm, T2
Shin, Y3
-
6
-
-
0030873165
-
Pieces of 8-bioactive fragments of extracellular proteins as regulators of angiogenesis
-
EH Sage Pieces of 8-bioactive fragments of extracellular proteins as regulators of angiogenesis Trends Cell Biol 7 1997 182 186
-
(1997)
Trends Cell Biol
, vol.7
, pp. 182-186
-
-
Sage, EH1
-
7
-
-
0030930671
-
Kringle-5 of plasminogen is a novel inhibitor of endothelial-cell growth
-
YH Cao A Chen SSA An Kringle-5 of plasminogen is a novel inhibitor of endothelial-cell growth J Biol Chem 272 1997 22924 22928
-
(1997)
J Biol Chem
, vol.272
, pp. 22924-22928
-
-
Cao, YH1
Chen, A2
An, SSA3
-
8
-
-
12644251975
-
The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin
-
S Gately P Twardowski MS Stack The mechanism of cancer-mediated conversion of plasminogen to the angiogenesis inhibitor angiostatin Proc Natl Acad Sci USA 94 1997 10868 10872
-
(1997)
Proc Natl Acad Sci USA
, vol.94
, pp. 10868-10872
-
-
Gately, S1
Twardowski, P2
Stack, MS3
-
9
-
-
0030998660
-
Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma
-
Z Dong R Kumar X Yang IJ Fidler Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma Cell 88 1997 801 810
-
(1997)
Cell
, vol.88
, pp. 801-810
-
-
Dong, Z1
Kumar, R2
Yang, X3
Fidler, IJ4
-
10
-
-
0028951043
-
Dormancy of micrometastases-balanced proliferation and apoptosis in the presence of angiogenesis suppression
-
L Holmgren MS O'Reilly J Folkman Dormancy of micrometastases-balanced proliferation and apoptosis in the presence of angiogenesis suppression Nat Med 1 1995 149 153
-
(1995)
Nat Med
, vol.1
, pp. 149-153
-
-
Holmgren, L1
O'Reilly, MS2
Folkman, J3
-
11
-
-
0029944122
-
Angiostatin induces and sustains dormancy of human primary tumours in mice
-
MS O'Reilly L Holmgren C Chen J Folkman Angiostatin induces and sustains dormancy of human primary tumours in mice Nat Med 2 1996 689 692
-
(1996)
Nat Med
, vol.2
, pp. 689-692
-
-
O'Reilly, MS1
Holmgren, L2
Chen, C3
Folkman, J4
-
12
-
-
0031469819
-
Antiangiogenic therapy of experimental cancer does not induce acquired drug-resistance
-
T Boehm J Folkman T Browder MS O'Reilly Antiangiogenic therapy of experimental cancer does not induce acquired drug-resistance Nature 390 1997 404 407
-
(1997)
Nature
, vol.390
, pp. 404-407
-
-
Boehm, T1
Folkman, J2
Browder, T3
O'Reilly, MS4
-
13
-
-
0030935029
-
A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer
-
BKL Sim MS O'Reilly H Liang A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer Cancer Res 57 1997 1329 1334
-
(1997)
Cancer Res
, vol.57
, pp. 1329-1334
-
-
Sim, BKL1
O'Reilly, MS2
Liang, H3
-
14
-
-
0032536859
-
Crystal-structure of the angiogenesis inhibitor endostatin at 1·5 angstrom resolution
-
E Hohenester T Sasaki BR Olsen R Timpl Crystal-structure of the angiogenesis inhibitor endostatin at 1·5 angstrom resolution EMBO J 17 1998 1656 1664
-
(1998)
EMBO J
, vol.17
, pp. 1656-1664
-
-
Hohenester, E1
Sasaki, T2
Olsen, BR3
Timpl, R4
-
15
-
-
0002853251
-
Angiogenesis antagonists: current clinical trials
-
S Brem Angiogenesis antagonists: current clinical trials Angiogenesis 2 1998 9 20
-
(1998)
Angiogenesis
, vol.2
, pp. 9-20
-
-
Brem, S1
-
16
-
-
0030722076
-
Non-small-cell-lung carcinoma tumor-growth without morphological evidence of neo-angiogenesis
-
F Pezzella U Pastorino E Tagliabue Non-small-cell-lung carcinoma tumor-growth without morphological evidence of neo-angiogenesis Am J Pathol 151 1997 1417 1423
-
(1997)
Am J Pathol
, vol.151
, pp. 1417-1423
-
-
Pezzella, F1
Pastorino, U2
Tagliabue, E3
|